Mizuho Analysts Give Kindred Healthcare (KND) a $9.00 Price Target

Mizuho set a $9.00 price target on Kindred Healthcare (NYSE:KND) in a report released on Monday. The brokerage currently has a hold rating on the health services provider’s stock.

A number of other research analysts have also recently commented on the company. Zacks Investment Research cut Kindred Healthcare from a hold rating to a sell rating in a research note on Wednesday, August 30th. Royal Bank of Canada reaffirmed a sector perform rating and set a $8.50 target price (up previously from $7.50) on shares of Kindred Healthcare in a research note on Thursday, November 9th. ValuEngine raised Kindred Healthcare from a sell rating to a hold rating in a research note on Thursday, November 9th. Deutsche Bank reaffirmed a hold rating and set a $9.00 target price (down previously from $10.00) on shares of Kindred Healthcare in a research note on Monday, September 18th. Finally, Stifel Nicolaus raised Kindred Healthcare from a sell rating to a hold rating and set a $7.00 target price on the stock in a research note on Monday, November 20th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of $9.07.

Shares of Kindred Healthcare (NYSE KND) opened at $9.15 on Monday. The company has a debt-to-equity ratio of 6.22, a quick ratio of 1.53 and a current ratio of 1.55. Kindred Healthcare has a 52 week low of $5.50 and a 52 week high of $11.90. The firm has a market capitalization of $791.09, a P/E ratio of 45.50, a price-to-earnings-growth ratio of 3.79 and a beta of 1.21.

Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.19) by $0.08. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The firm’s revenue for the quarter was down 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.05 earnings per share. equities analysts predict that Kindred Healthcare will post 0.32 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. California Public Employees Retirement System boosted its holdings in shares of Kindred Healthcare by 14.6% in the third quarter. California Public Employees Retirement System now owns 751,962 shares of the health services provider’s stock valued at $5,113,000 after purchasing an additional 95,543 shares during the period. Cubist Systematic Strategies LLC boosted its holdings in shares of Kindred Healthcare by 1,071.1% in the third quarter. Cubist Systematic Strategies LLC now owns 40,228 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 36,793 shares during the period. Continental Advisors LLC purchased a new stake in shares of Kindred Healthcare in the third quarter valued at approximately $306,000. Highbridge Capital Management LLC purchased a new stake in shares of Kindred Healthcare in the third quarter valued at approximately $133,000. Finally, Royce & Associates LP boosted its holdings in shares of Kindred Healthcare by 8.9% in the third quarter. Royce & Associates LP now owns 1,199,050 shares of the health services provider’s stock valued at $8,154,000 after purchasing an additional 97,500 shares during the period. Hedge funds and other institutional investors own 89.59% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/12/21/mizuho-analysts-give-kindred-healthcare-knd-a-9-00-price-target.html.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit